Michaela Schlederer
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Cytokine Signaling Pathways and Interactions
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
Papers in
- Oncology 18
- Cytokine Signaling Pathways and Interactions 9
- Cancer Cells and Metastasis 3
- Cancer Immunotherapy and Biomarkers 3
-
- Epigenetics and DNA Methylation 4
- Ubiquitin and proteasome pathways 3
- Histone Deacetylase Inhibitors Research 3
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Lukas Kenner (38 shared papers)Richard Moriggl (14 shared papers)Helmut Dolznig (4 shared papers)Markus Hengstschläger (3 shared papers)Nina Kramer (3 shared papers)Christine Unger (2 shared papers)Stefanie Walter (2 shared papers)Daniela Unterleuthner (2 shared papers)
- Journals
- Oncotarget (4 papers)PLoS ONE (3 papers)Journal of Personalized Medicine (2 papers)Diabetologia (2 papers)Cancer Research (2 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Michaela Schlederer
37 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 106
- Oncology 712
- Cancer Research 279
- Immunology 263
- Molecular Biology 814
- Pathology and Forensic Medicine 177
Countries citing papers authored by Michaela Schlederer
This map shows the geographic impact of Michaela Schlederer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Schlederer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Schlederer more than expected).
Fields of papers citing papers by Michaela Schlederer
This network shows the impact of papers produced by Michaela Schlederer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Schlederer. The network helps show where Michaela Schlederer may publish in the future.
Co-authors
The 25 scholars most cited alongside Michaela Schlederer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 334 | |
| 2 | 2016 | 328 | |
| 3 | 2016 | 182 | |
| 4 | 2010 | 159 | |
| 5 | 2009 | 135 | |
| 6 | 2011 | 85 | |
| 7 | 2013 | 73 | |
| 8 | 2013 | 72 | |
| 9 | 2014 | 71 | |
| 10 | 2017 | 62 | |
| 11 | 2009 | 58 | |
| 12 | 2016 | 52 | |
| 13 | 2015 | 46 | |
| 14 | 2011 | 41 | |
| 15 | 2015 | 37 | |
| 16 | 2010 | 37 | |
| 17 | 2018 | 31 | |
| 18 | 2016 | 30 | |
| 19 | 2012 | 25 | |
| 20 | 2014 | 24 |
About Michaela Schlederer
Michaela Schlederer is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Pathology and Forensic Medicine, having authored 40 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (9 papers), Epigenetics and DNA Methylation (4 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Cells and Metastasis (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Oncology (712 citations), Cancer Research (279 citations), Immunology (263 citations), Molecular Biology (814 citations) and Pathology and Forensic Medicine (177 citations). Michaela Schlederer has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Lukas Kenner, Richard Moriggl, Helmut Dolznig, Markus Hengstschläger, Nina Kramer, Christine Unger, Stefanie Walter, Daniela Unterleuthner, Mira Stadler and Nasser K. Altorki. Their work appears in journals such as Oncotarget, PLoS ONE, Journal of Personalized Medicine, Diabetologia and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.